Abstract:BackgroundThe expanded use of multiple drugs has increased the occurrence of adverse drug reactions (ADRs) induced by drug-drug interactions (DDIs). However, such reactions are typically not observed in clinical drug-development studies because most of them focus on single-drug therapies. ADR reporting systems collect information on adverse health effects caused by both single drugs and DDIs. A major challenge is to unambiguously identify the effects caused by DDIs and to attribute them to specific drug interactions. A computational method that provides prospective predictions of potential DDI-induced ADRs will help to identify and mitigate these adverse health effects.MethodWe hypothesize that drug-protein interactions can be used as independent variables in predicting ADRs. We constructed drug pair-protein interaction profiles for ~800 drugs using drug-protein interaction information in the public domain. We then constructed statistical models to score drug pairs for their potential to induce ADRs based on drug pair-protein interaction profiles.ResultsWe used extensive clinical database information to construct categorical prediction models for drug pairs that are likely to induce ADRs via synergistic DDIs and showed that model performance deteriorated only slightly, with a moderate amount of false positives and false negatives in the training samples, as evaluated by our cross-validation analysis. The cross validation calculations showed an average prediction accuracy of 89% across 1,096 ADR models that captured the deleterious effects of synergistic DDIs. Because the models rely on drug-protein interactions, we made predictions for pairwise combinations of 764 drugs that are currently on the market and for which drug-protein interaction information is available. These predictions are publicly accessible at http://avoid-db.bhsai.org. We used the predictive models to analyze broader aspects of DDI-induced ADRs, showing that ~10% of all combinations have the potential to induce ADRs via DDIs. This allowed us to identify potential DDI-induced ADRs not yet clinically reported. The ability of the models to quantify adverse effects between drug classes also suggests that we may be able to select drug combinations that minimize the risk of ADRs.ConclusionAlmost all information on DDI-induced ADRs is generated after drug approval. This situation poses significant health risks for vulnerable patient populations with comorbidities. To help mitigate the risks, we developed a robust probabilistic approach to prospectively predict DDI-induced ADRs. Based on this approach, we developed prediction models for 1,096 ADRs and used them to predict the propensity of all pairwise combinations of nearly 800 drugs to be associated with these ADRs via DDIs. We made the predictions publicly available via internet access.

ADRVis: an Information Visualization Platform for Adverse Drug Reactions

Study of Serious Adverse Drug Reactions Using FDA-approved Drug Labeling and MedDRA

Establishment of the visualization platform for ADR query and analysis: an example of severe skin adverse reactions caused by sulfonylureas (Preprint)

Establishment of a Rapid Identification of Adverse Drug Reaction Program in R Language Implementation Based on Monitoring Data

Automatic assessment of adverse drug reaction reports with interactive visual exploration

A Survey on Computational Approaches to Predicting Adverse Drug Reactions.

Interactive crowdsourcing to spontaneous reporting of Adverse Drug Reactions

Detecting Potential Adverse Drug Reactions Using Association Rules and Embedding Models.

BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs

Mining and Visualizing High-Order Directional Drug Interaction Effects Using the FAERS Database

Application of Association Rules Analysis in Mining Adverse Drug Reaction Signals

Data-driven prediction of adverse drug reactions induced by drug-drug interactions

ADReCS-Target: Target Profiles for Aiding Drug Safety Research and Application.

Detect Adverse Drug Reactions for Drug Aspirin

ADRNet: A Generalized Collaborative Filtering Framework Combining Clinical and Non-Clinical Data for Adverse Drug Reaction Prediction

ADReCS: an Ontology Database for Aiding Standardization and Hierarchical Classification of Adverse Drug Reaction Terms

Filtering Big Data from Social Media - Building an Early Warning System for Adverse Drug Reactions

Construction of Drug Adverse Reaction/Event Monitoring Platform in a Medical Institution

Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study

Exploring the associations between drug side-effects and therapeutic indications.

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms